Compare IMMP & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMP | CRWS |
|---|---|---|
| Founded | 1987 | 1957 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 29.4M |
| IPO Year | 2012 | 1994 |
| Metric | IMMP | CRWS |
|---|---|---|
| Price | $3.60 | $2.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 303.6K | 80.4K |
| Earning Date | 09-01-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 4.94% |
| EPS Growth | N/A | ★ 118.89 |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $70,270,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.29 |
| Revenue Growth | N/A | ★ 6.51 |
| 52 Week Low | $0.26 | $2.35 |
| 52 Week High | $5.36 | $3.14 |
| Indicator | IMMP | CRWS |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 25.96 |
| Support Level | $2.65 | N/A |
| Resistance Level | $5.36 | $2.61 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 64.73 | 0.00 |
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.